Free Trial
Notice: This company has been marked as potentially delisted and may not be actively trading.
NYSE:MNK

Mallinckrodt (MNK) Stock Price, News & Analysis

Mallinckrodt logo

About Mallinckrodt Stock (NYSE:MNK)

Advanced Chart

Key Stats

Today's Range
N/A
50-Day Range
$0.14
$0.75
52-Week Range
N/A
Volume
39,227 shs
Average Volume
2.62 million shs
Market Capitalization
$1.58 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
Consensus Rating
N/A

Company Overview

Mallinckrodt Plc is a global specialty pharmaceuticals company. It develops, manufactures, markets and distributes both branded and generic specialty pharmaceutical products and medical imaging agents. It operates through the Specialty Brands and Specialty Generics segments. The Specialty Brands segment includes branded medicines. The Specialty Generics segment relates to specialty generic drugs, active pharmaceutical ingredients, as well as external manufacturing. The company was founded by Gustavo Mallinckrodt, Otto Mallinckrodt and Edward Mallinckrodt in 1867 and is headquartered in Blanchardstown, Dublin.

Receive MNK Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Mallinckrodt and its competitors with MarketBeat's FREE daily newsletter.

MNK Stock News Headlines

Mallinckrodt Completes Divestiture of Therakos® Business
January 29th - the next big trading catalyst to watch
Mark your calendar for January 29th. Because on that day, I believe we could see a $2 Trillion shock INTO the market… Unleashing more explosive moves than ever before.
See More Headlines

MNK Stock Analysis - Frequently Asked Questions

Mallinckrodt plc (NYSE:MNK) announced its quarterly earnings data on Tuesday, August, 4th. The company reported $1.89 earnings per share for the quarter, beating analysts' consensus estimates of $1.34 by $0.55. The company's revenue for the quarter was down 14.9% compared to the same quarter last year.
Read the conference call transcript
.

Based on aggregate information from My MarketBeat watchlists, some other companies that Mallinckrodt investors own include Bristol-Myers Squibb (BMY), Gilead Sciences (GILD), Micron Technology (MU), Endo International (ENDP), Bausch Health Companies (BHC), Meta Platforms (META) and Gerdau (GGB).

Company Calendar

Last Earnings
8/04/2020
Today
1/21/2025
Fiscal Year End
12/31/2025

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
N/A
Fax
N/A
Employees
2,700
Year Founded
N/A

Profitability

Pretax Margin
N/A

Debt

Sales & Book Value

Annual Sales
N/A
Book Value
$47.48 per share

Miscellaneous

Free Float
13,131,000
Market Cap
$1.58 million
Optionable
Not Optionable
Beta
N/A
The Best High-Yield Dividend Stocks for 2024 Cover

Looking to generate income with your stock portfolio? Use these ten stocks to generate a safe and reliable source of investment income.

Get This Free Report

This page (NYSE:MNK) was last updated on 1/22/2025 by MarketBeat.com Staff
From Our Partners